Latest Breaking News On - Alina jucov - Page 2 : comparemela.com

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Jin hongKusum guptaLawrence blattTongfei wuVeronica eamesCorey davisYannick debingJinlin houAlina jucovExchange commission onExchange commissionAligos therapeutics incLifesci communicationsTherapeutics presents dataLiver disease programsEuropean association

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

-Presentations include a late breaking poster from an ongoing Phase 1b study of ALG-000184 demonstrating multi-log reductions in HBsAg, DNA, and RNA levels in subjects dosed for up to 36 weeks- -Data collectively highlight company’s progress advanc.

Tongfei wuLawrence blattAlina jucovKusum guptaJin hongVeronica eamesJinlin houYannick debingCorey davisAligos therapeutics incLifesci communicationsExchange commissionExchange commission onEuropean associationScientific presentationsLate breaking poster

Aligos Therapeutics to Present Data on its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

SOUTH SAN FRANCISCO, Calif., June 07, 2023 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver. | June 7, 2023

Alina jucovYannick debingJinlin houVeronica eamesCorey davisKusum guptaTongfei wuJin hongLawrence blattLifesci communicationsExchange commissionExchange commission onAligos therapeutics incEuropean associationScientific presentationsSecurities litigation reform act

Aligos Therapeutics to Present Data from Chronic Hepatitis

SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company.

Jin hongLawrence blattAlina jucovCorey davisKusum guptaJinlin houYannick debingAmy jobeTongfei wuExchange commissionExchange commission onAligos therapeutics incLifesci communicationsEuropean associationScientific presentationsSecurities litigation reform act

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Jinlin houCorey davisKusum guptaYannick debingAmy jobeJin hongAlina jucovLawrence blattTongfei wuLifesci communicationsExchange commissionAligos therapeutics incExchange commission onEuropean associationScientific presentationsSecurities litigation reform act